Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative

Addiction Medicine: Beyond the Abstract by Shawn McNeil, MD

Sep 18, 202526:02Science & Medicine

Dr. Pouya Azar stops by the show to talk about his recent article Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative. He discusses the potenti...

Related Episodes

Continue listening to more episodes from Addiction Medicine: Beyond the Abstract.

Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds

Sep 4, 2026 - 23:26

In this episode, infectious diseases physician Dr. Liz Novick stops by to discuss her recent study Clinic...

Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique

Aug 20, 2026 - 32:27

In today's episode, Drs. Nicole Malette and Paxton Bach join the show to discuss their new article Approa...

The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine

Aug 7, 2026 - 18:20

In this episode, Dr. Jeanmarie Perrone sits down to discuss her new article The Shifting Landscape of a F...

The Role of Childhood Trauma in Chronic Pain and Substance Use Among Individuals Receiving Methadone Treatment for Opioid Use Disorder

Jul 24, 2026 - 23:24

In this episode of Beyond The Abstract, Dr. Joao De Aquino joins the show to talk about his new article T...

Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial

May 28, 2026 - 22:34

In this episode of Beyond The Abstract, Dr. Manish Jha stops by to talk about his new article Craving, Im...